← Comparing 1 hypotheses side-by-side
Add hypothesis:
— Select a hypothesis to add —
Metabolic Reprogramming to Reverse Senescence (SIRT1,PGC1A,NAMPT) — 1.00 Closed-loop transcranial focused ultrasound with 40Hz gamma (PVALB) — 1.00 TREM2-Dependent Astrocyte-Microglia Cross-talk in Neurodegen (TREM2) — 0.99 SASP Modulation Rather Than Cell Elimination (NFKB1,IL1B,BDNF) — 0.98 TREM2-Dependent Microglial Senescence Transition (TREM2) — 0.95 Closed-loop transcranial focused ultrasound targeting EC-II (SST) — 0.95 Closed-loop optogenetic targeting PV interneurons to restore (PVALB) — 0.94 PLCG2 Allosteric Modulation as a Precision Therapeutic for T (PLCG2) — 0.94 Plasma p-tau217-Triggered Exosome Dosing Maximizes lncRNA-00 (CSF p-tau217 (biomarker), lncRNA-0021, hUC-MSC exosomes) — 0.94 Multi-Biomarker Composite Index Surpassing Amyloid PET for T (COMPOSITE_BIOMARKER) — 0.93 Closed-loop focused ultrasound targeting CA1 PV interneurons (PVALB) — 0.93 Closed-loop transcranial focused ultrasound targeting EC-II (SST) — 0.92 CYP46A1 Gene Therapy for Age-Related TREM2-Mediated Microgli (CYP46A1) — 0.92 Autophagy-Senescence Axis Therapeutic Window (ATG7,BCL2,BCL2L1) — 0.92 Selective Acid Sphingomyelinase Modulation Therapy (SMPD1) — 0.92 HK2-Dependent Metabolic Checkpoint as the Gatekeeper of DAM (HK2) — 0.92 Palmitoylethanolamide-Based Endocannabinoid Therapy (PPARA) — 0.92 CYP46A1 Overexpression Gene Therapy (CYP46A1) — 0.92 Chromatin Remodeling-Mediated Nutrient Sensing Restoration (SMARCA4) — 0.91 Closed-loop transcranial focused ultrasound to restore hippo (CCK) — 0.91 SASP-Mediated Complement Cascade Amplification (C1Q/C3) — 0.91 TREM2-ASM Crosstalk in Microglial Lysosomal Senescence (SMPD1) — 0.91 TREM2-Mediated Astrocyte-Microglia Cross-Talk in Neurodegene (TREM2) — 0.91 Nutrient-Sensing Epigenetic Circuit Reactivation (SIRT1) — 0.91 Closed-loop focused ultrasound targeting EC-II SST interneur (SST) — 0.90 CSF1R Inhibition-Mediated Microglial Replacement as a State (CSF1R) — 0.90 Closed-loop tACS targeting EC-II SST interneurons to block t (SST) — 0.90 SIRT1-Mediated Reversal of TREM2-Dependent Microglial Senesc (SIRT1) — 0.90 TREM2-Mediated Astrocyte-Microglia Crosstalk in Neurodegener (TREM2) — 0.89 Hypothesis 4: Metabolic Coupling via Lactate-Shuttling Colla (SLC16A1, SLC16A7, LDHA, PDHA1) — 0.89
Add
|
× Peripheral-to-Central Inf
IL1B · - · therapeutic
Composite 0.626
Price $0.67
Evidence For 0
Evidence Against 0
## Mechanistic Overview
Peripheral-to-Central Inflammation Circuit Breaker starts from the claim that modulating IL1B within the disease context of neurodegeneration can redirect a disease-relevant process. The original description reads: "## Mechanistic Overview Peripheral-to-Central Inflammation Circuit Breaker starts from the claim that modulating IL1B within the disease context of neurodegeneration can redirect a disease-relevant process. The original description reads: "**Background and Rat
Radar Chart — 10 Dimensions
Score Breakdown
Dimension Peripheral-to-Central Inflamma Mechanistic 0.700 Evidence 0.615 Novelty 0.000 Feasibility 0.000 Impact 0.000 Druggability 0.600 Safety 0.600 Competition 0.400 Data 0.400 Reproducible 0.300 KG Connect 0.837
Evidence Peripheral-to-Central Inflammation Circuit Breaker No evidence citations yet
Price History Overlay
Knowledge Graph Comparison
Peripheral-to-Central Inflammation Circu
12 edges
Top Node Types gene 8
disease 2
pathway 1
process 1
Top Relations investigated_in 3
interacts_with_confidence_0.775 1
associated_with 1
interacts_with_confidence_0.993 1
causes 1